BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33826275)

  • 1. [The Saga of Vaccines against Covid-19].
    Saliou P
    Bull Soc Pathol Exot; 2020; 113(4):185-186. PubMed ID: 33826275
    [No Abstract]   [Full Text] [Related]  

  • 2. Equitable global access to coronavirus disease 2019 vaccines.
    Schwartz JL
    BMJ; 2020 Dec; 371():m4735. PubMed ID: 33323384
    [No Abstract]   [Full Text] [Related]  

  • 3. Public opinion on global rollout of COVID-19 vaccines.
    Clarke PM; Roope LSJ; Loewen PJ; Bonnefon JF; Melegaro A; Friedman J; Violato M; Barnett A; Duch R
    Nat Med; 2021 Jun; 27(6):935-936. PubMed ID: 33785911
    [No Abstract]   [Full Text] [Related]  

  • 4. Key populations for early COVID-19 immunization: preliminary guidance for policy.
    Ismail SJ; Zhao L; Tunis MC; Deeks SL; Quach C;
    CMAJ; 2020 Nov; 192(48):E1620-E1632. PubMed ID: 33144317
    [No Abstract]   [Full Text] [Related]  

  • 5. The UK has approved a COVID vaccine - here's what scientists now want to know.
    Ledford H; Cyranoski D; Van Noorden R
    Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic.
    Mallapaty S
    Nature; 2021 Jun; 594(7862):161-162. PubMed ID: 34089030
    [No Abstract]   [Full Text] [Related]  

  • 7. Covid-19 vaccine passports: access, equity, and ethics.
    Osama T; Razai MS; Majeed A
    BMJ; 2021 Apr; 373():n861. PubMed ID: 33795260
    [No Abstract]   [Full Text] [Related]  

  • 8. A network analysis of COVID-19 mRNA vaccine patents.
    Gaviria M; Kilic B
    Nat Biotechnol; 2021 May; 39(5):546-548. PubMed ID: 33981074
    [No Abstract]   [Full Text] [Related]  

  • 9. [COVID-19: Warp Speed vaccines].
    Feraoun Y; Maisonnasse P; Le Grand R; Beignon AS
    Med Sci (Paris); 2021; 37(8-9):759-772. PubMed ID: 34080537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing.
    Fischer JC; Schmidt AG; Bölke E; Keitel V; Feldt T; Jensen B; Freise NF; Häussinger D; Schneider EM; Hermsen D; Kindgen-Milles D; Knoefel WT; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Rox J; Balz V; Maas K; Schmidt L; Grebe O; Ehrhardt A; Gerber PA; Peiper M; Buhren BA; Lichtenberg A; Rezazadeh A; Budach W; Matuschek C
    Eur J Med Res; 2021 Aug; 26(1):87. PubMed ID: 34362461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
    Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
    [No Abstract]   [Full Text] [Related]  

  • 12. A Reserve System for the Equitable Allocation of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Makhoul AT; Drolet BC
    Chest; 2021 Mar; 159(3):1292-1293. PubMed ID: 33453180
    [No Abstract]   [Full Text] [Related]  

  • 13. The world's largest COVID-19 vaccination campaign.
    Bagcchi S
    Lancet Infect Dis; 2021 Mar; 21(3):323. PubMed ID: 33639124
    [No Abstract]   [Full Text] [Related]  

  • 14. Covid-19 vaccines and new mutant strains impacting the pandemic.
    Matta S; Rajpal S; Chopra KK; Arora VK
    Indian J Tuberc; 2021 Apr; 68(2):171-173. PubMed ID: 33845947
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-amplifying RNA vaccines for infectious diseases.
    Bloom K; van den Berg F; Arbuthnot P
    Gene Ther; 2021 Apr; 28(3-4):117-129. PubMed ID: 33093657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK science advisers: publish evidence behind COVID vaccine changes.
    Nature; 2021 Jan; 589(7841):169-170. PubMed ID: 33437064
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 Vaccines: Current Understanding on Immunogenicity, Safety, and Further Considerations.
    He Q; Mao Q; Zhang J; Bian L; Gao F; Wang J; Xu M; Liang Z
    Front Immunol; 2021; 12():669339. PubMed ID: 33912196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Messenger RNA vaccines against SARS-CoV-2.
    Topol EJ
    Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.
    Lombardi A; Bozzi G; Ungaro R; Villa S; Castelli V; Mangioni D; Muscatello A; Gori A; Bandera A
    Front Immunol; 2021; 12():657711. PubMed ID: 33777055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.